NCT00005989View on ClinicalTrials.gov

R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2002

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Lung Cancer
Interventions
DRUG

tipifarnib

Trial Locations (3)

55905

Mayo Clinic, Rochester

60637

University of Chicago Cancer Research Center, Chicago

Unknown

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER